India Clinical Trials Market By Region, Competition, Forecast & Opportunities, 2020-2024 & 2024-2030 [Yahoo! Finance]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Yahoo! Finance
India Clinical Trials Market was valued at USD 2.05 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.64% through 2030 The Clinical Trials Market refers to the global industry involved in the operation and management of clinical trials, which are crucial research investigations. In these trials, individuals voluntarily participate to test new treatments, interventions, or tests that aim to prevent, detect, treat, or manage various diseases or medical conditions. By conducting these trials, researchers aim to determine not only the safety and effectiveness but also the scalability of new drugs or treatments, ensuring their potential impact on a larger scale. This market encompasses a wide range of stakeholders, including pharmaceutical companies, contract research organizations, healthcare providers, academic institutes, and more. All these entities collaborate in a concerted effort, playing a pivotal role in accelerating the p
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Moderna (MRNA) Q3 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024Business Wire
- IQVIA Holdings Inc. (NYSE: IQV) had its price target lowered by analysts at JPMorgan Chase & Co. from $279.00 to $240.00. They now have an "overweight" rating on the stock.MarketBeat
- IQVIA Holdings Inc. (NYSE: IQV) had its price target lowered by analysts at Truist Financial Co. from $286.00 to $265.00. They now have a "buy" rating on the stock.MarketBeat
- IQVIA Holdings Inc. (NYSE: IQV) had its price target lowered by analysts at Morgan Stanley from $280.00 to $265.00. They now have an "overweight" rating on the stock.MarketBeat
IQV
Earnings
- 10/31/24 - Beat
IQV
Sec Filings
- 11/8/24 - Form 4
- 11/8/24 - Form 4
- 11/8/24 - Form 4
- IQV's page on the SEC website